Existing research on CRMP2 phosphorylation mechanisms, regardless of whether it targets nerve injury or neurodegenerative disease models, ultimately aims to resolve the challenges associated with human neuropathy. The gene discussed is DPYSL2; the disease is neurodegenerative disease.